Loading…

n–3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation

The present work was performed to study an optimal dose and duration of dietary n-3 polyunsaturated fatty acid (PUFA) supplementation that would not result in harmful modifications of oxidative cell metabolism. Forty healthy subjects were divided into four groups that received 2.5 g/d eicosapentaeno...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of clinical nutrition 1996-09, Vol.64 (3), p.297-304
Main Authors: Palozza, P, Sgarlata, E, Luberto, C, Piccioni, E, Anti, M, Marra, G, Armelao, F, Franceschelli, P, Bartoli, GM
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3
cites cdi_FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3
container_end_page 304
container_issue 3
container_start_page 297
container_title The American journal of clinical nutrition
container_volume 64
creator Palozza, P
Sgarlata, E
Luberto, C
Piccioni, E
Anti, M
Marra, G
Armelao, F
Franceschelli, P
Bartoli, GM
description The present work was performed to study an optimal dose and duration of dietary n-3 polyunsaturated fatty acid (PUFA) supplementation that would not result in harmful modifications of oxidative cell metabolism. Forty healthy subjects were divided into four groups that received 2.5 g/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA), 5.1 g EPA + DHA/d, 7.7 g EPA + DHA/d, or placebo. Fatty acid composition, tocopherol status, and susceptibility to lipid peroxidation induced in vitro by 2,2′-azobis-(2-amidinopropane) (AAPH) were evaluated in human red blood cell (RBC) membranes on days 30 and 180. n-3 PUFA treatment increased EPA and DHA concentrations in RBC membranes in a time-dependent manner in all of the n-3 PUFA groups. These modifications occurred with concomitant dose- and time-dependent increases in the membrane unsaturation index. After 30 d of treatment with n-3 PUFAs, alpha-to-copherol significantly increased in RBC membranes of the intermediate- and high-dose groups. Because of the higher concentration of this antioxidant in these groups, the susceptibility of RBC membranes to peroxidation was decreased. However, after 180 d of treatment, alpha-tocopherol decreased to baseline values and AAPH-induced lipid peroxidation increased in a dose-dependent manner. These results show that high doses of dietary n-3 PUFAs, as well as long-time treatments, affect human RBC susceptibility to lipid peroxidation by changes in fatty acid composition and tocopherol content.
doi_str_mv 10.1093/ajcn/64.3.297
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_231918587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000291652317393X</els_id><sourcerecordid>10185162</sourcerecordid><originalsourceid>FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3</originalsourceid><addsrcrecordid>eNp1kctuEzEUhi0EKqGwZIlkIbaT-jIZzyxRVS5SJTawtk6Oz1BHGXuwPRXZ9R14Q54Ep4m6Y2Ud_d-56DNjb6VYSzHoK9hhuOratV6rwTxjKznovtFKmOdsJYRQzSC7zUv2KuedEFK1fXfBLnrTC63Nij2Evw9_NB-hlAMH9C5zH9yCxONv76D4e-JTdH70WIsYjjG_WyYInNKh3KWIh0KZO5opOB9-8hi4i5k4BMfdkh67eBy581QgHXhe5nlPE4XyGL1mL0bYZ3pzfi_Zj08336-_NLffPn-9_njbYDuY0tAWyYxDC-BUp9CBMJ1UqtfSOCPRkDQIiMoIpwTAFjYCpB5og6RHB1t9yd6f5s4p_looF7uLSwp1pVVaDrLf9KZCzQnCFHNONNo5-alebaWwR9v2aNt2rdW22q78u_PQZTuRe6LPemv-4ZxDRtiPCQL6_ITVXxJ9rytmThhVAfeeks3oKSA5nwiLddH_54B_oSefpQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>231918587</pqid></control><display><type>article</type><title>n–3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation</title><source>ScienceDirect®</source><creator>Palozza, P ; Sgarlata, E ; Luberto, C ; Piccioni, E ; Anti, M ; Marra, G ; Armelao, F ; Franceschelli, P ; Bartoli, GM</creator><creatorcontrib>Palozza, P ; Sgarlata, E ; Luberto, C ; Piccioni, E ; Anti, M ; Marra, G ; Armelao, F ; Franceschelli, P ; Bartoli, GM</creatorcontrib><description>The present work was performed to study an optimal dose and duration of dietary n-3 polyunsaturated fatty acid (PUFA) supplementation that would not result in harmful modifications of oxidative cell metabolism. Forty healthy subjects were divided into four groups that received 2.5 g/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA), 5.1 g EPA + DHA/d, 7.7 g EPA + DHA/d, or placebo. Fatty acid composition, tocopherol status, and susceptibility to lipid peroxidation induced in vitro by 2,2′-azobis-(2-amidinopropane) (AAPH) were evaluated in human red blood cell (RBC) membranes on days 30 and 180. n-3 PUFA treatment increased EPA and DHA concentrations in RBC membranes in a time-dependent manner in all of the n-3 PUFA groups. These modifications occurred with concomitant dose- and time-dependent increases in the membrane unsaturation index. After 30 d of treatment with n-3 PUFAs, alpha-to-copherol significantly increased in RBC membranes of the intermediate- and high-dose groups. Because of the higher concentration of this antioxidant in these groups, the susceptibility of RBC membranes to peroxidation was decreased. However, after 180 d of treatment, alpha-tocopherol decreased to baseline values and AAPH-induced lipid peroxidation increased in a dose-dependent manner. These results show that high doses of dietary n-3 PUFAs, as well as long-time treatments, affect human RBC susceptibility to lipid peroxidation by changes in fatty acid composition and tocopherol content.</description><identifier>ISSN: 0002-9165</identifier><identifier>EISSN: 1938-3207</identifier><identifier>DOI: 10.1093/ajcn/64.3.297</identifier><identifier>PMID: 8780337</identifier><identifier>CODEN: AJCNAC</identifier><language>eng</language><publisher>Bethesda, MD: Elsevier Inc</publisher><subject>Adult ; Amidines - pharmacology ; Biological and medical sciences ; Blood ; Diet ; Dietary Fats - pharmacology ; Docosahexaenoic Acids - pharmacology ; Dose-Response Relationship, Drug ; Eicosapentaenoic Acid - pharmacology ; Erythrocyte Membrane - drug effects ; Erythrocyte Membrane - metabolism ; Fatty Acids, Omega-3 - blood ; Fatty Acids, Omega-3 - pharmacology ; Feeding. Feeding behavior ; Female ; Food, Fortified ; Fundamental and applied biological sciences. Psychology ; Humans ; Lipid Peroxides - metabolism ; Male ; Middle Aged ; Nutrition ; Oils &amp; fats ; Oxidation ; Oxidation-Reduction ; Time Factors ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vitamin E ; Vitamin E - blood</subject><ispartof>The American journal of clinical nutrition, 1996-09, Vol.64 (3), p.297-304</ispartof><rights>1996 American Society for Nutrition.</rights><rights>1996 INIST-CNRS</rights><rights>Copyright American Society for Clinical Nutrition, Inc. Sep 1996</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3</citedby><cites>FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S000291652317393X$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45779</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3200883$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8780337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Palozza, P</creatorcontrib><creatorcontrib>Sgarlata, E</creatorcontrib><creatorcontrib>Luberto, C</creatorcontrib><creatorcontrib>Piccioni, E</creatorcontrib><creatorcontrib>Anti, M</creatorcontrib><creatorcontrib>Marra, G</creatorcontrib><creatorcontrib>Armelao, F</creatorcontrib><creatorcontrib>Franceschelli, P</creatorcontrib><creatorcontrib>Bartoli, GM</creatorcontrib><title>n–3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation</title><title>The American journal of clinical nutrition</title><addtitle>Am J Clin Nutr</addtitle><description>The present work was performed to study an optimal dose and duration of dietary n-3 polyunsaturated fatty acid (PUFA) supplementation that would not result in harmful modifications of oxidative cell metabolism. Forty healthy subjects were divided into four groups that received 2.5 g/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA), 5.1 g EPA + DHA/d, 7.7 g EPA + DHA/d, or placebo. Fatty acid composition, tocopherol status, and susceptibility to lipid peroxidation induced in vitro by 2,2′-azobis-(2-amidinopropane) (AAPH) were evaluated in human red blood cell (RBC) membranes on days 30 and 180. n-3 PUFA treatment increased EPA and DHA concentrations in RBC membranes in a time-dependent manner in all of the n-3 PUFA groups. These modifications occurred with concomitant dose- and time-dependent increases in the membrane unsaturation index. After 30 d of treatment with n-3 PUFAs, alpha-to-copherol significantly increased in RBC membranes of the intermediate- and high-dose groups. Because of the higher concentration of this antioxidant in these groups, the susceptibility of RBC membranes to peroxidation was decreased. However, after 180 d of treatment, alpha-tocopherol decreased to baseline values and AAPH-induced lipid peroxidation increased in a dose-dependent manner. These results show that high doses of dietary n-3 PUFAs, as well as long-time treatments, affect human RBC susceptibility to lipid peroxidation by changes in fatty acid composition and tocopherol content.</description><subject>Adult</subject><subject>Amidines - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Blood</subject><subject>Diet</subject><subject>Dietary Fats - pharmacology</subject><subject>Docosahexaenoic Acids - pharmacology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Eicosapentaenoic Acid - pharmacology</subject><subject>Erythrocyte Membrane - drug effects</subject><subject>Erythrocyte Membrane - metabolism</subject><subject>Fatty Acids, Omega-3 - blood</subject><subject>Fatty Acids, Omega-3 - pharmacology</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Food, Fortified</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Lipid Peroxides - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nutrition</subject><subject>Oils &amp; fats</subject><subject>Oxidation</subject><subject>Oxidation-Reduction</subject><subject>Time Factors</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vitamin E</subject><subject>Vitamin E - blood</subject><issn>0002-9165</issn><issn>1938-3207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNp1kctuEzEUhi0EKqGwZIlkIbaT-jIZzyxRVS5SJTawtk6Oz1BHGXuwPRXZ9R14Q54Ep4m6Y2Ud_d-56DNjb6VYSzHoK9hhuOratV6rwTxjKznovtFKmOdsJYRQzSC7zUv2KuedEFK1fXfBLnrTC63Nij2Evw9_NB-hlAMH9C5zH9yCxONv76D4e-JTdH70WIsYjjG_WyYInNKh3KWIh0KZO5opOB9-8hi4i5k4BMfdkh67eBy581QgHXhe5nlPE4XyGL1mL0bYZ3pzfi_Zj08336-_NLffPn-9_njbYDuY0tAWyYxDC-BUp9CBMJ1UqtfSOCPRkDQIiMoIpwTAFjYCpB5og6RHB1t9yd6f5s4p_looF7uLSwp1pVVaDrLf9KZCzQnCFHNONNo5-alebaWwR9v2aNt2rdW22q78u_PQZTuRe6LPemv-4ZxDRtiPCQL6_ITVXxJ9rytmThhVAfeeks3oKSA5nwiLddH_54B_oSefpQ</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>Palozza, P</creator><creator>Sgarlata, E</creator><creator>Luberto, C</creator><creator>Piccioni, E</creator><creator>Anti, M</creator><creator>Marra, G</creator><creator>Armelao, F</creator><creator>Franceschelli, P</creator><creator>Bartoli, GM</creator><general>Elsevier Inc</general><general>American Society for Clinical Nutrition</general><general>American Society for Clinical Nutrition, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T7</scope><scope>7TS</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope></search><sort><creationdate>19960901</creationdate><title>n–3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation</title><author>Palozza, P ; Sgarlata, E ; Luberto, C ; Piccioni, E ; Anti, M ; Marra, G ; Armelao, F ; Franceschelli, P ; Bartoli, GM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Adult</topic><topic>Amidines - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Blood</topic><topic>Diet</topic><topic>Dietary Fats - pharmacology</topic><topic>Docosahexaenoic Acids - pharmacology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Eicosapentaenoic Acid - pharmacology</topic><topic>Erythrocyte Membrane - drug effects</topic><topic>Erythrocyte Membrane - metabolism</topic><topic>Fatty Acids, Omega-3 - blood</topic><topic>Fatty Acids, Omega-3 - pharmacology</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Food, Fortified</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Lipid Peroxides - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nutrition</topic><topic>Oils &amp; fats</topic><topic>Oxidation</topic><topic>Oxidation-Reduction</topic><topic>Time Factors</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vitamin E</topic><topic>Vitamin E - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Palozza, P</creatorcontrib><creatorcontrib>Sgarlata, E</creatorcontrib><creatorcontrib>Luberto, C</creatorcontrib><creatorcontrib>Piccioni, E</creatorcontrib><creatorcontrib>Anti, M</creatorcontrib><creatorcontrib>Marra, G</creatorcontrib><creatorcontrib>Armelao, F</creatorcontrib><creatorcontrib>Franceschelli, P</creatorcontrib><creatorcontrib>Bartoli, GM</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Physical Education Index</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>The American journal of clinical nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Palozza, P</au><au>Sgarlata, E</au><au>Luberto, C</au><au>Piccioni, E</au><au>Anti, M</au><au>Marra, G</au><au>Armelao, F</au><au>Franceschelli, P</au><au>Bartoli, GM</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>n–3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation</atitle><jtitle>The American journal of clinical nutrition</jtitle><addtitle>Am J Clin Nutr</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>64</volume><issue>3</issue><spage>297</spage><epage>304</epage><pages>297-304</pages><issn>0002-9165</issn><eissn>1938-3207</eissn><coden>AJCNAC</coden><abstract>The present work was performed to study an optimal dose and duration of dietary n-3 polyunsaturated fatty acid (PUFA) supplementation that would not result in harmful modifications of oxidative cell metabolism. Forty healthy subjects were divided into four groups that received 2.5 g/d eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA), 5.1 g EPA + DHA/d, 7.7 g EPA + DHA/d, or placebo. Fatty acid composition, tocopherol status, and susceptibility to lipid peroxidation induced in vitro by 2,2′-azobis-(2-amidinopropane) (AAPH) were evaluated in human red blood cell (RBC) membranes on days 30 and 180. n-3 PUFA treatment increased EPA and DHA concentrations in RBC membranes in a time-dependent manner in all of the n-3 PUFA groups. These modifications occurred with concomitant dose- and time-dependent increases in the membrane unsaturation index. After 30 d of treatment with n-3 PUFAs, alpha-to-copherol significantly increased in RBC membranes of the intermediate- and high-dose groups. Because of the higher concentration of this antioxidant in these groups, the susceptibility of RBC membranes to peroxidation was decreased. However, after 180 d of treatment, alpha-tocopherol decreased to baseline values and AAPH-induced lipid peroxidation increased in a dose-dependent manner. These results show that high doses of dietary n-3 PUFAs, as well as long-time treatments, affect human RBC susceptibility to lipid peroxidation by changes in fatty acid composition and tocopherol content.</abstract><cop>Bethesda, MD</cop><pub>Elsevier Inc</pub><pmid>8780337</pmid><doi>10.1093/ajcn/64.3.297</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9165
ispartof The American journal of clinical nutrition, 1996-09, Vol.64 (3), p.297-304
issn 0002-9165
1938-3207
language eng
recordid cdi_proquest_journals_231918587
source ScienceDirect®
subjects Adult
Amidines - pharmacology
Biological and medical sciences
Blood
Diet
Dietary Fats - pharmacology
Docosahexaenoic Acids - pharmacology
Dose-Response Relationship, Drug
Eicosapentaenoic Acid - pharmacology
Erythrocyte Membrane - drug effects
Erythrocyte Membrane - metabolism
Fatty Acids, Omega-3 - blood
Fatty Acids, Omega-3 - pharmacology
Feeding. Feeding behavior
Female
Food, Fortified
Fundamental and applied biological sciences. Psychology
Humans
Lipid Peroxides - metabolism
Male
Middle Aged
Nutrition
Oils & fats
Oxidation
Oxidation-Reduction
Time Factors
Vertebrates: anatomy and physiology, studies on body, several organs or systems
Vitamin E
Vitamin E - blood
title n–3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T07%3A39%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=n%E2%80%933%20fatty%20acids%20induce%20oxidative%20modifications%20in%20human%20erythrocytes%20depending%20on%20dose%20and%20duration%20of%20dietary%20supplementation&rft.jtitle=The%20American%20journal%20of%20clinical%20nutrition&rft.au=Palozza,%20P&rft.date=1996-09-01&rft.volume=64&rft.issue=3&rft.spage=297&rft.epage=304&rft.pages=297-304&rft.issn=0002-9165&rft.eissn=1938-3207&rft.coden=AJCNAC&rft_id=info:doi/10.1093/ajcn/64.3.297&rft_dat=%3Cproquest_cross%3E10185162%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c497t-ebce7f94aad262cda0761228317d71c7e17cacc270d20aaba50a139e5ce3fdab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=231918587&rft_id=info:pmid/8780337&rfr_iscdi=true